Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Saori, Watanabe"'
Publikováno v:
Regenerative Therapy, Vol 26, Iss , Pp 831-836 (2024)
When the International Society for Stem Cell Research revised its 2021 guidelines, it reversed its ban on the in vitro culture of human embryos beyond 14 days. However, despite widespread recognition of the importance of public debate on embryo resea
Externí odkaz:
https://doaj.org/article/38bf359314b24454a2efdfc57c80b902
Autor:
Hideki Yui, Yoshimi Yashiro, Kaori Muto, Saori Watanabe, Yukitaka Kiya, Yusuke Inoue, Zentaro Yamagata
Publikováno v:
Regenerative Therapy, Vol 26, Iss , Pp 9-13 (2024)
Rules and ethical considerations regarding research on embryo models have been debated across numerous countries. In this paper, we provide insights from our attitude survey conducted among Japanese researchers, including members of the Japanese Soci
Externí odkaz:
https://doaj.org/article/dda00cbee52a497ebe6d83bf22703e4d
Autor:
Midori Yamasaki, Toshiyuki Maki, Taisuke Mochida, Teruki Hamada, Saori Watanabe-Matsumoto, Shuhei Konagaya, Manami Kaneko, Ryo Ito, Hikaru Ueno, Taro Toyoda
Publikováno v:
Cell Transplantation, Vol 33 (2024)
In the development of cell therapy products, immunocompromised animal models closer in size to humans are valuable for enhancing the translatability of in vivo findings to clinical trials. In the present study, we generated immunocompromised type 1 d
Externí odkaz:
https://doaj.org/article/930002bc43534fc4ae15819b48168a79
Autor:
Hideki Yui, Ayako Kamisato, Kaori Muto, Yoshimi Yashiro, Saori Watanabe, Yukitaka Kiya, Kumiko Fujisawa, Yusuke Inoue, Zentaro Yamagata
Publikováno v:
Regenerative Therapy, Vol 24, Iss , Pp 78-84 (2023)
Introduction: The rules for human fetal tissue (HFT) research in Japan are unclear. Methods: In this paper, we conducted a web survey to examine the attitudes of Japanese researchers (n=535) and the public (n=3,000) toward HFT research. Results: The
Externí odkaz:
https://doaj.org/article/6751c66056e24799adb360735cee3726
Autor:
Haruka Nakada, Saori Watanabe, Kyoko Takashima, Shohei Suzuki, Yuki Kawamura, Yutori Takai, Kenji Matsui, Keiichiro Yamamoto
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 18, Iss 1, Pp 1-12 (2023)
Abstract Background Rare diseases (RDs) may impose a considerable financial burden on patients and their families. Public acceptance is essential to ensure sustainable public systems supporting RDs, especially in countries with universal healthcare c
Externí odkaz:
https://doaj.org/article/6bbd61499bf4450aaaad5b8d945ec9da
Autor:
Kensuke Sakuma, Noriko Tsubooka-Yamazoe, Kiyohiro Hashimoto, Nozomu Sakai, Shinya Asano, Saori Watanabe-Matsumoto, Takeshi Watanabe, Bunnai Saito, Hirokazu Matsumoto, Hikaru Ueno, Ryo Ito, Taro Toyoda
Publikováno v:
Stem Cell Research & Therapy, Vol 14, Iss 1, Pp 1-15 (2023)
Abstract Background Transplantation of differentiated cells from human-induced pluripotent stem cells (hiPSCs) holds great promise for clinical treatments. Eliminating the risk factor of malignant cell transformation is essential for ensuring the saf
Externí odkaz:
https://doaj.org/article/a21dd5df379540a8874afc1118b6fef0
Autor:
Hideki Yui, Kaori Muto, Yoshimi Yashiro, Saori Watanabe, Yukitaka Kiya, Ayako Kamisato, Yusuke Inoue, Zentaro Yamagata
Publikováno v:
Regenerative Therapy, Vol 21, Iss , Pp 46-51 (2022)
This paper presents a comparison of the 2021 guidelines for stem cell research and clinical translation outlined by the International Society for Stem Cell Research (ISSCR) with the current regulations in Japan regarding the performance of such resea
Externí odkaz:
https://doaj.org/article/5575ba0b2e404ce9bc4b843ed62e6c6b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Takeshi Mikami, Kagami Hirabayashi, Keisuke Okawa, Tetsuo Betsuyaku, Saori Watanabe, Yuki Imamura, Kimihiko Tanizawa, Takuya Hayashi, Masaharu Akao, Takeshi Yamashita, Ken Okumura
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 17 (2022)
Background We investigated the predictors related to major bleeding events during treatment with edoxaban 15 mg in patients aged ≥80 years with nonvalvular atrial fibrillation and high bleeding risk, for whom standard oral anticoagulants are inappr
Externí odkaz:
https://doaj.org/article/f65986955c7d4c509943ba7426db9191
Autor:
Hideki Yui, Kaori Muto, Yoshimi Yashiro, Saori Watanabe, Yukitaka Kiya, Kumiko Fujisawa, Kana Harada, Yusuke Inoue, Zentaro Yamagata
Publikováno v:
Stem Cell Reports. 18:799-806
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df37cfbb147e467da81ed3f051530b0c
https://doi.org/10.1016/j.stemcr.2023.02.005
https://doi.org/10.1016/j.stemcr.2023.02.005